Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Brain Mechanisms of Topiramate's Effects on Heavy Drinking

Trial Profile

Brain Mechanisms of Topiramate's Effects on Heavy Drinking

Discontinued
Phase of Trial: Phase II

Latest Information Update: 13 Dec 2017

At a glance

  • Drugs Topiramate (Primary)
  • Indications Alcoholism; Epilepsy
  • Focus Pharmacodynamics
  • Acronyms TOP-MRI
  • Most Recent Events

    • 06 Dec 2017 Status changed from recruiting to discontinued.
    • 19 Feb 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 09 Dec 2014 Planned number of patients changed from 30 to 40 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top